To explore the significance of TBC1D15 in TISC-mediated oncogenesis, we carried out in vivo tumor formation titration assays in which defined numbers of TISCs were implanted subcutaneously into immune-compromised NOD/Shi-scid, IL-2Rγ null (NOG) mice. The gene discussed is TBC1D15; the disease is neoplasm.